Venture Capital

Chinese Biotech Startup D3 Bio Raises $200M In Series A Round

by dealstreetasia.com posted 6months ago 195 views
Boyu Capital, Matrix Partners China, Sequoia Capital China, Temasek and WuXi AppTec unit joined the round. The post Chinese biotech startup D3 Bio raises $200m in Series A round appeared first on DealStreetAsia.